Prescription medication · Alpha-1 Blocker

prazosin

Also sold as Minipress. Prazosin is used to treat high blood pressure.

Data updated 2026-05-15

5,825
FDA reportsLightly reported
11
InteractionsSeveral interactions
In shortage
FDA status

What the data shows

prazosin (Minipress) is a prescription Alpha-1 Blocker, reported less often than most tracked drugs (5,825 FDA reports), with 11 documented drug interactions.

Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.

prazosin (Minipress) is a prescription Alpha-1 Blocker. Prazosin is used to treat high blood pressure.

Prazosin (Minipress) is a medicine that lowers your blood pressure. Lowering blood pressure helps prevent strokes and heart attacks.

Drug Shortage Alert

prazosin is currently listed as to be discontinued by the FDA. Affected manufacturer: Pfizer Inc..

View all drug shortages →

Drug Pricing (NADAC)

Generic Price

$0.11/unit

Generic Available

Yes (10 manufacturers)

Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →

View Alternatives → Compare with Another Drug → Full Side Effects Report →

What it does

Prazosin is used to treat high blood pressure.

Common side effects

Dizziness, Headache, Drowsiness

Key warnings

Prazosin can cause a sudden drop in blood pressure, especially when you first start taking it.

The sections below are summarized in plain English from prazosin's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.

How It Works

Prazosin belongs to a class of drugs called alpha-1 blockers. It works by relaxing your blood vessels. This makes it easier for blood to flow through your body, which lowers blood pressure.

Side Effects (from patient reports)

Based on 5,825 FDA adverse event reports.

Most-reported reactions

Adverse reactions in FAERS for prazosin, by number of reports

reports

What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.

Source FDA Adverse Event Reporting System (FAERS) As of 2025

Reports over time

Adverse-event reports filed for prazosin each year to the FDA Adverse Event Reporting System (FAERS).

0200400600800 200120062009201220152018202120242025 449

Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.

Where prazosin sits

prazosin has more FDA adverse-event reports than 27% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.

fewest reports most reports

Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is prazosin; the line is the median (50th percentile).

FDA Adverse Event Report Analysis

Detailed analysis of 5,825 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2001–2025.

Total Reports

5,825

Reports Mentioning Death

676

11.6% of reports — not proof of cause

Hospitalization Reports

2,125

Top Indication

Product Used For Unknown Indication

Gender Distribution

Female 3,076 (57%)
Male 2,283 (43%)

Age Distribution

0–17 265
18–44 1,564
45–64 1,537
65–74 530
75+ 360

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
2 NAUSEA 361
4 HEADACHE 265
5 DIZZINESS 263
6 ANXIETY 260
7 FATIGUE 257
8 PAIN 254
9 VOMITING 246
10 DEPRESSION 239
11 DRUG INTERACTION 233
12 DIARRHOEA 227
13 SUICIDAL IDEATION 220
14 DYSPNOEA 212
15 FALL 211
16 TOXICITY TO VARIOUS AGENTS 203
17 HYPOTENSION 201

Reactions in Death Reports

COMPLETED SUICIDE 191
DEATH 111
TOXICITY TO VARIOUS AGENTS 100
CARDIO-RESPIRATORY ARREST 75
DRUG INTERACTION 50
CARDIAC ARREST 41
NAUSEA 40
DECREASED APPETITE 38
VOMITING 37
OROPHARYNGEAL PAIN 34

Reactions in Hospitalization Reports

TOXICITY TO VARIOUS AGENTS 140
HYPOTENSION 128
VOMITING 110
NAUSEA 104
FALL 102
DRUG INTERACTION 92
ANXIETY 91
DIARRHOEA 91
DYSPNOEA 90
ACUTE KIDNEY INJURY 87

Source: FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

Prazosin can cause a sudden drop in blood pressure, especially when you first start taking it. This can make you feel dizzy or faint. To avoid this, take your first dose at bedtime. Be careful when standing up quickly.

Known Drug Interactions

Drug Interactions Prazosin hydrochloride has been administered without any adverse drug interaction in limited clinical experience to date with the following: (1) cardiac glycosides– digitalis and digoxin; (2) hypoglycemics–insulin, chlorpropamide, phenformin, tolazamide, and tolbutamide; (3) tranquilizers and sedatives–chlordiazepoxide, diazepam, and phenobarbital; (4) antigout– allopurinol, colchicine, and probenecid; (5) antiarrhythmics–procainamide, propranolol ( see WARNINGS however), and quinidine; and (6) analgesics, antipyretics and anti-inflammatories– propoxyphene, aspirin,...

Mechanism: There is no evidence that these two medications cause problems when taken together.

minor aspirin

Drug Interactions Prazosin hydrochloride has been administered without any adverse drug interaction in limited clinical experience to date with the following: (1) cardiac glycosides– digitalis and digoxin; (2) hypoglycemics–insulin, chlorpropamide, phenformin, tolazamide, and tolbutamide; (3) tranquilizers and sedatives–chlordiazepoxide, diazepam, and phenobarbital; (4) antigout– allopurinol, colchicine, and probenecid; (5) antiarrhythmics–procainamide, propranolol ( see WARNINGS however), and quinidine; and (6) analgesics, antipyretics and anti-inflammatories– propoxyphene, aspirin,...

Mechanism: Prazosin and aspirin do not have a known negative reaction when used together. They appear to work safely in the body without interfering with each other.

Drug Interactions Prazosin hydrochloride has been administered without any adverse drug interaction in limited clinical experience to date with the following: (1) cardiac glycosides– digitalis and digoxin; (2) hypoglycemics–insulin, chlorpropamide, phenformin, tolazamide, and tolbutamide; (3) tranquilizers and sedatives–chlordiazepoxide, diazepam, and phenobarbital; (4) antigout– allopurinol, colchicine, and probenecid; (5) antiarrhythmics–procainamide, propranolol ( see WARNINGS however), and quinidine; and (6) analgesics, antipyretics and anti-inflammatories– propoxyphene, aspirin,...

Mechanism: These two drugs have been used together without causing any harmful side effects. They do not seem to change how the other medication works in the body.

minor digoxin

Drug Interactions Prazosin hydrochloride has been administered without any adverse drug interaction in limited clinical experience to date with the following: (1) cardiac glycosides– digitalis and digoxin; (2) hypoglycemics–insulin, chlorpropamide, phenformin, tolazamide, and tolbutamide; (3) tranquilizers and sedatives–chlordiazepoxide, diazepam, and phenobarbital; (4) antigout– allopurinol, colchicine, and probenecid; (5) antiarrhythmics–procainamide, propranolol ( see WARNINGS however), and quinidine; and (6) analgesics, antipyretics and anti-inflammatories– propoxyphene, aspirin,...

Mechanism: There is no evidence that these drugs cause problems when taken at the same time. They do not appear to affect each other's safety or effectiveness.

Drug Interactions Prazosin hydrochloride has been administered without any adverse drug interaction in limited clinical experience to date with the following: (1) cardiac glycosides– digitalis and digoxin; (2) hypoglycemics–insulin, chlorpropamide, phenformin, tolazamide, and tolbutamide; (3) tranquilizers and sedatives–chlordiazepoxide, diazepam, and phenobarbital; (4) antigout– allopurinol, colchicine, and probenecid; (5) antiarrhythmics–procainamide, propranolol ( see WARNINGS however), and quinidine; and (6) analgesics, antipyretics and anti-inflammatories– propoxyphene, aspirin,...

Mechanism: Based on limited clinical data, these drugs do not have a known harmful interaction. They appear to be compatible when taken together.

Check all your medications →

This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.

Common Questions

Can I drink alcohol while taking prazosin?
Talk to your doctor about drinking alcohol while taking prazosin. Alcohol can increase the blood pressure-lowering effects of prazosin.
Will prazosin cure my high blood pressure?
Prazosin helps control high blood pressure, but it is usually not a cure. You may need to take it for a long time.
Can I stop taking prazosin if I feel better?
Do not stop taking prazosin without talking to your doctor. Stopping suddenly can cause your blood pressure to rise quickly.
Does prazosin interact with other medications?
Yes, prazosin can interact with other medications, including those for erectile dysfunction. Tell your doctor about all the medicines you take.
How long does it take for prazosin to start working?
Prazosin starts working quickly to lower blood pressure, but it may take a few weeks to see the full effect.
Can prazosin cause weight gain?
Weight gain is not a common side effect of prazosin.
Can I take prazosin if I have kidney problems?
Talk to your doctor if you have kidney problems. They may need to adjust your dose.
Can prazosin affect my cholesterol?
Prazosin does not usually affect cholesterol levels.
Is it safe to drive while taking prazosin?
Prazosin can cause dizziness or drowsiness, especially when you first start taking it. Be careful driving or operating machinery until you know how it affects you.
What should I do if I feel dizzy after taking prazosin?
If you feel dizzy, sit or lie down until the dizziness passes. Avoid standing up quickly.
What are the common side effects of prazosin?
The registry lists Dizziness, Headache, Drowsiness, Lack of energy, Weakness among the most-reported FAERS reaction terms for prazosin. The compiled record contains 5,825 FDA adverse-event reports. These counts are not an individual symptom assessment.
Does prazosin interact with other medications?
The registry has 11 documented interaction rows for prazosin. Notable source-record pairings include allopurinol, aspirin, diazepam. These rows are not a complete medication review.
What drug class is prazosin?
prazosin belongs to the Alpha-1 Blocker drug class. It requires a prescription (Rx). Prazosin is used to treat high blood pressure.
What pregnancy or breastfeeding source fields are listed for prazosin?
The FDA label for prazosin contains product-specific pregnancy or breastfeeding language. PlainMeds does not apply that source text to an individual.
Has prazosin been recalled?
There are 6 recalls associated with prazosin products. cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits. Check the recalls section below for full details and affected products.
Is prazosin currently in shortage?
Yes, prazosin is currently listed as to be discontinued by the FDA. Affected manufacturer: Pfizer Inc.. Visit the FDA Drug Shortages database for the latest updates.

Active Recalls

Class II March 27, 2026

cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.

Appco Pharma LLC

Class II March 27, 2026

cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.

Appco Pharma LLC

Class II March 27, 2026

cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.

Appco Pharma LLC

Class II October 16, 2025

Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit

Amerisource Health Services LLC

Class II October 7, 2025

CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots.

Teva Pharmaceuticals USA, Inc

Class II October 7, 2025

CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots.

Teva Pharmaceuticals USA, Inc

Other drugs grouped near prazosin - same-class peers and common alternatives.

Compare prazosin vs acebutolol side-by-side →

Compare beyond drug class

Nationwide peers by FAERS volume & death-report share

Two PlainMeds-derived comparison paths for prazosin: nearest FDA FAERS report volume and nearest death-report share among drugs with at least 1,000 logged reports, excluding same-class neighbors listed above. Counts reflect reporting volume, not proven individual harm.

Medication Guides

Save on prazosin

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for prazosin

The FDA label for prazosin (sold under brand names such as Minipress) classifies it as a prescription-only medication in the Alpha-1 Blocker class. Prazosin is used to treat high blood pressure. Official labeling lists 6 commonly reported side effects, including Dizziness, Headache, Drowsiness.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 5,825 voluntary reports. The database also lists 11 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated minor severity. NADAC pricing from CMS shows a generic unit cost of $0.11.

Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history (currently 6 recall records on file), and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC). Shortage status: FDA Drug Shortages Database.

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.

Last updated: April 4, 2023

PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.

Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.

All federal data sources used on this page